Clinical Trial Update: Theophylline for Treatment of Pseudohypoparathyroidism [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating theophylline for treatment of pseudohypoparathyroidism; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albright Hereditary Osteodystrophy
• Pseudohypoparathyroidism
• Pseudohypoparathyroidism Type 1a

Drugs mentioned

• Theophylline (Theophylline)

Snippet

Sponsor: Ashley Shoemaker | Conditions: Pseudohypoparathyroidism, Pseudohypoparathyroidism Type 1a | Phase 2 | Status: ENROLLING_BY_INVITATION